John Aballi sold $270K of Exagen (XGN)

Executed Oct 16, disclosed Oct 19, 3 days later.

Value, as filed

$270K

34,294 sh × $7.87

Executed

Oct 16

the trade date, as filed

Disclosed

Oct 19

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

John Aballi President and CEO profile →

John Aballi (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exagen Inc. (XGN). The largest single filing was $270K of XGN (34,294 sh × $7.87, as filed), executed Oct 16.

The name

XGN

Exagen Inc. XGN · Healthcare · 7 filings in 24 months ticker →

Healthcare · Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John Aballi in XGN

XGNSALE Exagen Inc. $376K
31,787 sh × $11.82
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET